PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 4005-4013

  Sun, Yaping ^a   Sun, John ^a   Tomomi, Toubai ^a   Nieves, Evelyn ^a   Mathewson, Nathan ^a   Tamaki, Hiroya ^a   Evers, Rebecca ^a   Reddy, Pavan ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; INTERLEUKIN 6; MICRORNA; MICRORNA 142; MICRORNA 142 3P; MICRORNA 155; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CBFBETA; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC CONSERVATION; HEMATOPOIETIC CELL; IMMUNOMODULATION; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN TARGETING; RAT; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; DENDRITIC CELLS; DOWN-REGULATION; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICRORNAS; NIH 3T3 CELLS; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84876005906     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202911     Document Type: Article

References (34)

1. O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10: 111-122.
2. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Landgraf, P., M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S. Pfeffer, A. Rice, A. O. Kamphorst, M. Landthaler, et al. 2007. A mammalian micro-RNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
4. Fukao, T., Y. Fukuda, K. Kiga, J. Sharif, K. Hino, Y. Enomoto, A. Kawamura, K. Nakamura, T. Takeuchi, and M. Tanabe. 2007. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129: 617-631.
5. Fazi, F., A. Rosa, A. Fatica, V. Gelmetti, M. L. De Marchis, C. Nervi, and I. Bozzoni. 2005. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 123: 819-831.
6. Griffiths-Jones, S., H. K. Saini, S. van Dongen, and A. J. Enright. 2008. miR-Base: tools for microRNA genomics. Nucleic Acids Res. 36(Database issue): D154-D158.
7. Corcoran, D. L., K. V. Pandit, B. Gordon, A. Bhattacharjee, N. Kaminski, and P. V. Benos. 2009. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE 4: e5279.
8. Sun, Y., S. Varambally, C. A. Maher, Q. Cao, P. Chockley, T. Toubai, C. Malter, E. Nieves, I. Tawara, Y. Wang, et al. 2011. Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality. Blood 117: 6172-6183.
9. REG cells by targeting AC9 mRNA. EMBO Rep. 10: 180-185.
10. Li, Q. J., J. Chau, P. J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
11. Gauwerky, C. E., K. Huebner, M. Isobe, P. C. Nowell, and C. M. Croce. 1989. Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc. Natl. Acad. Sci. USA 86: 8867-8871.
12. Robbiani, D. F., S. Bunting, N. Feldhahn, A. Bothmer, J. Camps, S. Deroubaix, K. M. McBride, I. A. Klein, G. Stone, T. R. Eisenreich, et al. 2009. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 36: 631-641.
13. Saunthararajah, Y., P. Boccuni, and G. Nucifora. 2006. Combinatorial action of RUNX1 and PU.1 in the regulation of hematopoiesis. Crit. Rev. Eukaryot. Gene Expr. 16: 183-192.
14. Sieweke, M. H., and T. Graf. 1998. A transcription factor party during blood cell differentiation. Curr. Opin. Genet. Dev. 8: 545-551.
15. Waltzer, L., G. Ferjoux, L. Bataillé, and M. Haenlin. 2003. Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hema-topoiesis. EMBO J. 22: 6516-6525.
16. Ranish, J. A., N. Yudkovsky, and S. Hahn. 1999. Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev. 13: 49-63.
17. Schödel, J., S. Oikonomopoulos, J. Ragoussis, C. W. Pugh, P. J. Ratcliffe, and D. R. Mole. 2011. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117: e207-e217.
18. Sun, W., W. Shen, S. Yang, F. Hu, H. Li, and T. H. Zhu. 2010. miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β. Cell Res. 20: 1158-1169.
19. Kim, W. Y., M. Sieweke, E. Ogawa, H. J. Wee, U. Englmeier, T. Graf, and Y. Ito. 1999. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J. 18: 1609-1620.
20. Gu, T. L., T. L. Goetz, B. J. Graves, and N. A. Speck. 2000. Auto-inhibition and partner proteins, core-binding factor beta (CBFb) and Ets-1, modulate DNA binding by CBFa2 (AML1). Mol. Cell. Biol. 20: 91-103.
21. Nagai, Y., S. Akashi, M. Nagafuku, M. Ogata, Y. Iwakura, S. Akira, T. Kitamura, A. Kosugi, M. Kimoto, and K. Miyake. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3: 667-672.
22. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
23. Ceppi, M., P. M. Pereira, I. Dunand-Sauthier, E. Barras, W. Reith, M. A. Santos, and P. Pierre. 2009. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. USA 106: 2735-2740.
24. Calame, K. 2007. MicroRNA-155 function in B cells. Immunity 27: 825-827.
25. Thompson, R. C., M. Herscovitch, I. Zhao, T. J. Ford, and T. D. Gilmore. 2011. NF-κB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. J. Biol. Chem. 286: 1675-1682.
26. Hu, Y. L., S. Fong, C. Largman, and W. F. Shen. 2010. HOXA9 regulates miR-155 in hematopoietic cells. Nucleic Acids Res. 38: 5472-5478.
27. Ghani, S., P. Riemke, J. Schönheit, D. Lenze, J. Stumm, M. Hoogenkamp, A. Lagendijk, S. Heinz, C. Bonifer, J. Bakkers, et al. 2011. Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood 118: 2275-2284.
28. Doyle, S., S. Vaidya, R. O'Connell, H. Dadgostar, P. Dempsey, T. Wu, G. Rao, R. Sun, M. Haberland, R. Modlin, and G. Cheng. 2002. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17: 251-263.
29. Lu, Y. C, W. C. Yeh, and P. S. Ohashi. 2008. LPS/TLR4 signal transduction pathway. Cytokine. 42: 145-151.
30. Rosmarin, A. G., Z. Yang, and K. K. Resendes. 2005. Transcriptional regulation in myelopoiesis: hematopoietic fate choice, myeloid differentiation, and leuke-mogenesis. Exp. Hematol. 33: 131-143.
31. Friedman, A. D. 2002. Transcriptional regulation of granulocyte and monocyte development. Oncogene 21: 3377-3390.
32. Kanno, T., Y. Kanno, L. F. Chen, E. Ogawa, W. Y. Kim, and Y. Ito. 1998. Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor a subunit revealed in the presence of the b subunit. Mol. Cell. Biol. 18: 2444-2454.
33. Sharma, S., J. Liu, J. Wei, H. Yuan, T. Zhang, and N. H. Bishopric. 2012. Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy. EMBO Mol. Med. 4: 617-632.
34. Blobel, G. A. 2000. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95: 745-755.